search
Back to results

Evidence Based Mental Wellness Programming Online for Adults Across Chronic Physical Conditions (EMPOwer)

Primary Purpose

Primary Biliary Cholangitis, Heart Failure, Digestive Diseases

Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Online mind-body wellness program
Online mind-body wellness program + Weekly Check-ins
Sponsored by
University of Alberta
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Primary Biliary Cholangitis focused on measuring Mind Body Wellness, Depression, Anxiety, Quality of Life, Wellbeing, Yoga, Meditation, Psychology

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Adults ≥18 years of age Identified diagnosis of one of nine chronic conditions (Heart Failure, PBC, Digestive Disease, Cirrhosis, Cancer survivor, Post-transplant, Women who have experienced a cardiac event, Chronic Kidney Disease), or another general category for physical chronic conditions not captured by these nine English language proficiency to complete questionnaires and read the educational material Access to the Internet and a computer or smart device at home Exclusion Criteria: Receiving compassionate care Inability to provide informed written consent Severe psychiatric disorders (presence of uncontrolled schizophrenia, post-traumatic stress disorder (PTSD), and/or bipolar disorder unless approved to participate by their physician/psychologist; suicidality nearly every day) No access to the internet

Sites / Locations

  • University of AlbertaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

No Intervention

Experimental

Experimental

Arm Label

Waitlist Control

Online Program

Online Program + Weekly Check-ins

Arm Description

Online program (mindful movement, meditation, breathwork, psychology-based coping skills program)

Online program (mindful movement, meditation, breathwork, psychology-based coping skills program) + brief 1-to-1 weekly check-ins with a study team member

Outcomes

Primary Outcome Measures

Hospital Anxiety and Depression Scale (HADS)
Depression and anxiety will be measured on the Hospital Anxiety and Depression Scale. The minimum value is 0, the maximum is 21, and higher scores mean a worse outcome.

Secondary Outcome Measures

Modified Fatigue Impact Scale (MFIS)
The Modified Fatigue Impact Scale (MFIS) assesses the effect of fatigue on cognitive functioning, physical functioning, and psychosocial functioning. The minimum value is 0, the maximum value is 84, and higher scores mean a worse outcome.
Health Related Quality of Life
Health related quality of life captured by the quality-of-life Short Form Survey 12 (SF-12). The minimum value is 0, the maximum value is 100, and a higher score means a better outcome.
EQ-5D-5L
Cost utility analysis will be facilitated by the EQ-5D-5L which consists of 5- dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) where patients are asked to indicate their health state. The minimum value is 5, the maximum value is 25, and a higher score means a worse outcome.
Capability, Opportunity, Motivation, Behaviour (COM-B) Survey
Capability, opportunity, and motivation for behaviour change will be measured on the COM-B survey. The lowest score is 0, the highest score is 60, and higher scores indicate better outcomes.
Satisfaction and Adherence
Satisfaction and adherence will be measured using a self-report tool where participants indicate their satisfaction with program elements, and perceived adherence to the program over the study period. The minimum value is 4, the maximum value is 40, and a higher score means a better outcome.

Full Information

First Posted
March 9, 2023
Last Updated
October 14, 2023
Sponsor
University of Alberta
Collaborators
Canadian Institutes of Health Research (CIHR)
search

1. Study Identification

Unique Protocol Identification Number
NCT05786482
Brief Title
Evidence Based Mental Wellness Programming Online for Adults Across Chronic Physical Conditions
Acronym
EMPOwer
Official Title
Evidence Based Mental Wellness Programming Online for Adults Across Chronic Physical Conditions (EMPOwer) Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 12, 2023 (Actual)
Primary Completion Date
July 31, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Alberta
Collaborators
Canadian Institutes of Health Research (CIHR)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Chronic physical conditions are defined as conditions that require ongoing management and treatment over extended periods of time. Chronic physical conditions are not only leading causes of death and disability in North America but they are commonly associated with mental distress and reduced quality of life. Online mind-body wellness programming ranging from physical activity to mindfulness interventions has been shown to be effective in improving mental wellness in a variety of chronic disease populations, but there is a need to evaluate scalable ways to deliver these programs. Building upon a previously developed online wellness program for inflammatory bowel disease (IBD) and primary biliary cholangitis (PBC), the research team has developed a mind-body wellness program for adults ≥18 years of age living with different chronic conditions (e.g., cirrhosis, PBC, heart failure). The 12-week program will be delivered online, and include follow- along mindful movement, breathwork and meditation routines, and a psychology based coping skills program. In a three-armed randomized controlled trial, the study will assess the impact on the primary outcome of anxiety and depression as measured through the hospital anxiety and depression scale (HADS). At the beginning and the end of the 12-week research study, participants will complete surveys to assess secondary/exploratory outcome measures including quality of life, fatigue, frailty, demoralization, and healthcare usage. After the program, the research team will conduct interviews with participants to allow them to share their other feedback about the program. The researchers will also send surveys to the participants eight weeks after the program ends to assess longer- term impacts on primary and secondary outcomes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Primary Biliary Cholangitis, Heart Failure, Digestive Diseases, Women Who Have Experienced a Cardiac Event, Cirrhosis, Liver, Post-Transplant, Cancer, Chronic Kidney Diseases, Other Chronic Physical Condition
Keywords
Mind Body Wellness, Depression, Anxiety, Quality of Life, Wellbeing, Yoga, Meditation, Psychology

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
500 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Waitlist Control
Arm Type
No Intervention
Arm Title
Online Program
Arm Type
Experimental
Arm Description
Online program (mindful movement, meditation, breathwork, psychology-based coping skills program)
Arm Title
Online Program + Weekly Check-ins
Arm Type
Experimental
Arm Description
Online program (mindful movement, meditation, breathwork, psychology-based coping skills program) + brief 1-to-1 weekly check-ins with a study team member
Intervention Type
Behavioral
Intervention Name(s)
Online mind-body wellness program
Intervention Description
Online program (mindful movement, meditation, breathwork, psychology-based coping skills program)
Intervention Type
Behavioral
Intervention Name(s)
Online mind-body wellness program + Weekly Check-ins
Intervention Description
Online program (mindful movement, meditation, breathwork, psychology-based coping skills program) + brief weekly check-ins
Primary Outcome Measure Information:
Title
Hospital Anxiety and Depression Scale (HADS)
Description
Depression and anxiety will be measured on the Hospital Anxiety and Depression Scale. The minimum value is 0, the maximum is 21, and higher scores mean a worse outcome.
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Modified Fatigue Impact Scale (MFIS)
Description
The Modified Fatigue Impact Scale (MFIS) assesses the effect of fatigue on cognitive functioning, physical functioning, and psychosocial functioning. The minimum value is 0, the maximum value is 84, and higher scores mean a worse outcome.
Time Frame
12 weeks
Title
Health Related Quality of Life
Description
Health related quality of life captured by the quality-of-life Short Form Survey 12 (SF-12). The minimum value is 0, the maximum value is 100, and a higher score means a better outcome.
Time Frame
12 weeks
Title
EQ-5D-5L
Description
Cost utility analysis will be facilitated by the EQ-5D-5L which consists of 5- dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) where patients are asked to indicate their health state. The minimum value is 5, the maximum value is 25, and a higher score means a worse outcome.
Time Frame
12 weeks
Title
Capability, Opportunity, Motivation, Behaviour (COM-B) Survey
Description
Capability, opportunity, and motivation for behaviour change will be measured on the COM-B survey. The lowest score is 0, the highest score is 60, and higher scores indicate better outcomes.
Time Frame
12 weeks
Title
Satisfaction and Adherence
Description
Satisfaction and adherence will be measured using a self-report tool where participants indicate their satisfaction with program elements, and perceived adherence to the program over the study period. The minimum value is 4, the maximum value is 40, and a higher score means a better outcome.
Time Frame
12 weeks
Other Pre-specified Outcome Measures:
Title
Demoralization (Exploratory)
Description
Demoralization will be captured through self report using the Demoralization Scale-II. The minimum score is 0, the maximum score is 32, and a higher score means a worse outcome.
Time Frame
12 weeks
Title
Edmonton Frail Scale (Exploratory)
Description
Frailty will be captured using the Edmonton Frail Scale. The minimum score is 0, the maximum score is 17, and a higher score means a worse outcome.
Time Frame
12 weeks
Title
Fried Frailty (Exploratory)
Description
Frailty will be captured using the Fried Frailty Score. The minimum score is 0, the maximum score is 5, and a higher score means a worse outcome.
Time Frame
12 weeks
Title
Healthcare Usage (Exploratory)
Description
Healthcare usage will be measured using a self-report tool where participants indicate healthcare service usage during the study period.
Time Frame
12 weeks
Title
Sleep (Exploratory)
Description
Impacts on sleep will be captured through self-report using the Patient Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance Short Form 8a. The minimum score is 8, the maximum score is 56, and a lower score means a worse outcome.
Time Frame
12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adults ≥18 years of age Identified diagnosis of one of nine chronic conditions (Heart Failure, PBC, Digestive Disease, Cirrhosis, Cancer survivor, Post-transplant, Women who have experienced a cardiac event, Chronic Kidney Disease), or another general category for physical chronic conditions not captured by these nine English language proficiency to complete questionnaires and read the educational material Access to the Internet and a computer or smart device at home Exclusion Criteria: Receiving compassionate care Inability to provide informed written consent Severe psychiatric disorders (presence of uncontrolled schizophrenia, post-traumatic stress disorder (PTSD), and/or bipolar disorder unless approved to participate by their physician/psychologist; suicidality nearly every day) No access to the internet
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Puneeta Tandon, MD, MSc
Phone
780-492-9844
Email
ptandon@ualberta.ca
Facility Information:
Facility Name
University of Alberta
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T6G2X8
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Puneeta Tandon
Phone
780-492-3195
Email
ptandon@ualberta.ca

12. IPD Sharing Statement

Learn more about this trial

Evidence Based Mental Wellness Programming Online for Adults Across Chronic Physical Conditions

We'll reach out to this number within 24 hrs